Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 31 of 57
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
NCT03108885
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
NCT03242824
Real-Time Myocardial Perfusion Echocardiography in the ICU
NCT03173716
Hamstring Strain in High School Athletes
NCT03248011
Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer
NCT03106415
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913
Use of Intra-Operative Shear Wave Ultrasound Vibrometry for Characterization of Esophageal Malignant Tumors
NCT03211780
Movement and Sensation for Advanced Prosthetic Hands
NCT03259386
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
NCT03042728
Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers
NCT03316105
Argus II/ORCAM Device Study
NCT03248388
Midodrine Hydrochloride in Early Sepsis
NCT03129542
Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
NCT03172143
Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
NCT03440047
Environmental Factors to Increase Patient Comfort During Urodynamics Testing
NCT03317340
MANP in Hypertension and Metabolic Syndrome
NCT03781739
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
NCT03194698
Atrial Fibrillation Screening and Education Study
NCT03440762
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
NCT03035331
Ixekizumab in the Treatment of Bullous Pemphigoid
NCT03099538
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
NCT03211117
Low Dose Computed Tomography for Lung Cancer Screening
NCT03084835
Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD
NCT02713516
Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT03132532
Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma
NCT03202628
Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis
NCT03166319
Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment
NCT03207581
Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block
NCT03478735
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin
NCT03122886
Decision Aids to Improve Knowledge in Patients With Prostate Cancer
NCT03182998
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer
NCT02860000
Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study
NCT03154476
Progenitor Cells in Human Esophagus
NCT03108898
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
NCT03115424
Natural History of Eosinophilic Esophagitis
NCT03290482
Ultrasound Evaluation of Crohn's Disease
NCT03235180
Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue
NCT03220893
Cognitive Function After Treatment of Primary CNS Malignancy
NCT03055364
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
NCT03119883
The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
NCT03156504
The Impact of Professional Coaching on Early Career Academic Emergency Physicians
NCT03125330
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
NCT03033225
Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery
NCT03008369
EEG Cap for Identification of Non-Convulsive Status Epilepticus
NCT03138876
Ultrasound-Assisted Lumbar Puncture
NCT03167190
Lavender During Intrauterine Insemination
NCT03461055
The Relationship Between Age and Carpal Tunnel Size
NCT03294733
AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.
NCT03236103
Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery
NCT03135431
Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
NCT03075553
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.